Eventually DCTH will get all of these notes(stocks) registered and get on to normal trading. currently 74M shares outstanding, I believe, all the notes for DCTH to have working capital for continuing the FDA trials probably be about 250M so still have away to go.

Researchers concluded that the GEN2 CHEMOSAT system appears to have higher melphalan filter efficiency, more consistent performance, and appears safe but needs further validation.

Correct, now they make their own filters to assure quality control

http://delcath.com/reuters-news/?id=2301517

I thought we were in the RS proof Exchange A,B, Pink

Actually it is not a small sample, FDA is allowed to use reliable foreign data for many of the milestones needed on this FDA trial. With Dr. Simon Pedder, is a late trial expert for gathering all the data foreign and domestic. Don't be surprised if the trial recruiting is changed to a much smaller sample, due to existing success in Europe. Now that DCTH as the money, Well close by the end of this money, dilution should be ending. However, the RS allowed DCTH to access restricted funds, which should last for few months. All matter of time we will see $5 to $10 stock by this time next year

Most of the negative news presented in Nov

Voted down RS
RS approved by cashing in Series stock
RS 350:1
Post RS dropped from $11 to .04 in 7 trading days

DCTH now has money and stock to raise more money for FDA Trials P3 will end June 2019, Then we will see some real movement

How true.. I am So Confused

I been here awhile, What Happen
At shareholders meeting proxy voting, the shareholders voted down the RS. However, by cashing in some Series stock, Jenny was able to override the SH votes and approve a RS on Nov 3, the RS approved by the BOD was 350:1 for each 350 shares held you get 1 share.
This allowed DCTH to recover 499,000,000 shares leaving 1.4M outstanding.

The conversion, of shares and SP of $11 Post RS. However, in one week the SP went from $11 to around .10 per share, since then it has been on downward trend since.
at this point Hudson Bay who was suppose bail out DCTH, sold all their shares 25Million and two others sold shares equal to 33Million shares

Two unnamed investors whom DCTH has done business before stepped in to raise capital for DCTH, all based on RS. The initial investment was to be $1.5 per share post RS, but the price drop from $11 was so fast that it had to be changed to raise the 10M needed to release restricted funds and raise 10M capital to continue PH3 Trials

This is where we are now dilution of 330, million shares to raise the 10 Million, due to pissing off all the tutes and investors with a 350:1 split

Now we are waiting for more investors to support DCTH, hopefully by end of this month dilution will end.

Plenty of time since FDA approval of PH3 data collection will end in June 2019 if all goes according to plan

This is already a proven product in Europe, and over 450 Chemosats have been done with outstanding results. However, the USA management team led by Jenny Simpson

To get a full story go read the SEC filing, this is a summary.

I do believe FDA will approve, but get your camping gear will not happen until 2019

All time low is .015